Alexandre Puissant

5.2k total citations · 1 hit paper
59 papers, 3.1k citations indexed

About

Alexandre Puissant is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Alexandre Puissant has authored 59 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Hematology and 14 papers in Genetics. Recurrent topics in Alexandre Puissant's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Alexandre Puissant is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Alexandre Puissant collaborates with scholars based in France, United States and Sweden. Alexandre Puissant's co-authors include Patrick Auberger, Guillaume Robert, Nina Fenouille, Frédéric Luciano, Jill‐Patrice Cassuto, Sophie Raynaud, Arnaud Jacquel, Pascal Colosetti, Kimberly Stegmaier and Gabriela Alexe and has published in prestigious journals such as Nature Genetics, Blood and PLoS ONE.

In The Last Decade

Alexandre Puissant

57 papers receiving 3.1k citations

Hit Papers

Targeting MYCN in Neurobl... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
    2013 457 citations Alexandre Puissant, Stacey M. Frumm et al. Cancer Discovery profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alexandre Puissant 2.0k 828 699 454 429 59 3.1k
Mario P. Tschan 2.2k 1.1× 1.1k 1.4× 329 0.5× 767 1.7× 753 1.8× 116 3.6k
Chunrong Yu 2.2k 1.1× 305 0.4× 566 0.8× 669 1.5× 348 0.8× 49 3.0k
Jingxuan Pan 2.7k 1.3× 266 0.3× 591 0.8× 1.0k 2.3× 795 1.9× 90 4.1k
Pascal Colosetti 2.4k 1.2× 439 0.5× 352 0.5× 770 1.7× 580 1.4× 48 3.3k
Hiroya Asou 2.3k 1.2× 352 0.4× 869 1.2× 1.2k 2.7× 839 2.0× 70 3.9k
Jérôme Tamburini 2.2k 1.1× 250 0.3× 1.3k 1.8× 540 1.2× 446 1.0× 88 3.3k
Sophie Raynaud 1.2k 0.6× 301 0.4× 1.4k 2.0× 458 1.0× 202 0.5× 86 2.8k
Sarki A. Abdulkadir 2.6k 1.3× 349 0.4× 176 0.3× 1.2k 2.7× 881 2.1× 93 4.4k
Nicolas Chapuis 1.8k 0.9× 187 0.2× 970 1.4× 466 1.0× 399 0.9× 74 2.7k
Nelofer Syed 2.2k 1.1× 828 1.0× 79 0.1× 1.2k 2.7× 834 1.9× 67 3.5k

Countries citing papers authored by Alexandre Puissant

Since Specialization
Citations

This map shows the geographic impact of Alexandre Puissant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Puissant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Puissant more than expected).

Fields of papers citing papers by Alexandre Puissant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Puissant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Puissant. The network helps show where Alexandre Puissant may publish in the future.

Co-authorship network of co-authors of Alexandre Puissant

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Puissant. A scholar is included among the top collaborators of Alexandre Puissant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Puissant. Alexandre Puissant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolodych, Sergii, Rémy Castellano, Emmanuelle Josselin, et al.. (2024). INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment. Molecular Cancer Therapeutics. 23(8). 1159–1175. 1 indexed citations
2.
Fodil, Sofiane, Rathana Kim, Étienne Lengliné, et al.. (2024). Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia. Cytometry Part B Clinical Cytometry. 108(1). 86–94. 1 indexed citations
3.
Mi, Yang, Yichen Wang, Philipp Mertins, et al.. (2024). Failure to Execute Caspase Activation Drives Therapy Resistance in TP53 Mutated AML. Blood. 144(Supplement 1). 53–53.
4.
Benbarche, Salima, Cécile K. Lopez, Eralda Salataj, et al.. (2022). Screening of ETO2-GLIS2–induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia. Science Advances. 8(6). eabg9455–eabg9455. 9 indexed citations
5.
Lin, Kevin, Justine C. Rutter, Abigail Xie, et al.. (2020). Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer. Nature Genetics. 52(4). 408–417. 39 indexed citations
6.
Benajiba, Lina, Gabriela Alexe, Angela Su, et al.. (2018). Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML. Leukemia. 33(3). 800–804. 12 indexed citations
7.
Cordero, Eugenia, Alexandre Puissant, Jianmin Sun, et al.. (2016). Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML. Oncogene. 35(39). 5119–5131. 96 indexed citations
8.
Puissant, Alexandre, Stacey M. Frumm, Gabriela Alexe, et al.. (2013). Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition. Cancer Discovery. 3(3). 308–323. 457 indexed citations breakdown →
9.
Carnevale, Julia, Linda Ross, Alexandre Puissant, et al.. (2013). SYK regulates mTOR signaling in AML. Leukemia. 27(11). 2118–2128. 40 indexed citations
10.
Robert, Guillaume, Alexandre Puissant, Maeva Dufies, et al.. (2012). The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production. Cell Death and Differentiation. 19(11). 1769–1778. 20 indexed citations
11.
Puissant, Alexandre, Maeva Dufies, Nina Fenouille, et al.. (2012). Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. Journal of Molecular Cell Biology. 4(4). 207–220. 32 indexed citations
12.
Tomić, Tijana, Thomas Botton, Michaël Cerezo, et al.. (2011). Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death and Disease. 2(9). e199–e199. 250 indexed citations
13.
Dufies, Maeva, Arnaud Jacquel, Guillaume Robert, et al.. (2011). Mechanism of action of the multikinase inhibitor Foretinib. Cell Cycle. 10(23). 4138–4148. 25 indexed citations
14.
Genta‐Jouve, Grégory, Alexandre Puissant, Patrick Auberger, et al.. (2011). Structure elucidation of the new citharoxazole from the Mediterranean deep‐sea sponge Latrunculia (Biannulata) citharistae. Magnetic Resonance in Chemistry. 49(8). 533–536. 12 indexed citations
15.
Fenouille, Nina, Alexandre Puissant, Maeva Dufies, et al.. (2010). Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC. Cancer Research. 70(23). 9659–9670. 52 indexed citations
16.
Puissant, Alexandre, Guillaume Robert, Nina Fenouille, et al.. (2010). Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation. Cancer Research. 70(3). 1042–1052. 323 indexed citations
17.
Puissant, Alexandre & Patrick Auberger. (2010). AMPK- and p62/SQSTM1-dependent autophagy mediate Resveratrol-induced cell death in chronic myelogenous leukemia. Autophagy. 6(5). 655–657. 62 indexed citations
18.
Grosso, Sébastien, Alexandre Puissant, Maeva Dufies, et al.. (2009). Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors. Molecular Cancer Therapeutics. 8(7). 1924–1933. 67 indexed citations
19.
Gamas, Pascal, Sandrine Marchetti, Alexandre Puissant, et al.. (2009). Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. Leukemia. 23(8). 1500–1506. 20 indexed citations
20.
Botton, Thomas, Alexandre Puissant, Philippe Bahadoran, et al.. (2009). In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone. Journal of Investigative Dermatology. 129(5). 1208–1218. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mario P. Tschan Breakdown of academic impact, for papers by Chunrong Yu Breakdown of academic impact, for papers by Jingxuan Pan Breakdown of academic impact, for papers by Pascal Colosetti Breakdown of academic impact, for papers by Hiroya Asou Breakdown of academic impact, for papers by Jérôme Tamburini Breakdown of academic impact, for papers by Sophie Raynaud Breakdown of academic impact, for papers by Sarki A. Abdulkadir Breakdown of academic impact, for papers by Nicolas Chapuis Breakdown of academic impact, for papers by Nelofer Syed
Rankless by CCL
2026